To evaluate whether inhibiting Bcl-xL and Mcl-1 could lead to decreased ATP production in metabolically stressed cancer cells, A549 cells were exposed to a very low dose of JY-1-106 in addition to metabolic stress. The gene discussed is MCL1; the disease is cancer.